164 related articles for article (PubMed ID: 38698370)
21. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway.
Nomoto D; Baba Y; Liu Y; Tsutsuki H; Okadome K; Harada K; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Moroishi T; Komohara Y; Sawa T; Baba H
Cancer Lett; 2022 Apr; 530():59-67. PubMed ID: 35033591
[TBL] [Abstract][Full Text] [Related]
22. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
23. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
[TBL] [Abstract][Full Text] [Related]
24. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.
Binder Gallimidi A; Fischman S; Revach B; Bulvik R; Maliutina A; Rubinstein AM; Nussbaum G; Elkin M
Oncotarget; 2015 Sep; 6(26):22613-23. PubMed ID: 26158901
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
[TBL] [Abstract][Full Text] [Related]
26. Dysfunction of Cl
Kei Kakinouchi ; Yoshie S; Tsuji S; Murono S; Hazama A
Biochem Biophys Res Commun; 2021 May; 555():95-101. PubMed ID: 33813282
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
28. Human Primary Epithelial Cells Acquire an Epithelial-Mesenchymal-Transition Phenotype during Long-Term Infection by the Oral Opportunistic Pathogen,
Lee J; Roberts JS; Atanasova KR; Chowdhury N; Han K; Yilmaz Ö
Front Cell Infect Microbiol; 2017; 7():493. PubMed ID: 29250491
[No Abstract] [Full Text] [Related]
29. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
30. Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases.
Balasundaram P; Singh MK; Dinda AK; Thakar A; Yadav R
Diagn Pathol; 2014 Jul; 9():145. PubMed ID: 25047112
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma.
Sogabe Y; Suzuki H; Toyota M; Ogi K; Imai T; Nojima M; Sasaki Y; Hiratsuka H; Tokino T
Int J Oncol; 2008 Jun; 32(6):1253-61. PubMed ID: 18497987
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
[TBL] [Abstract][Full Text] [Related]
34. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
[TBL] [Abstract][Full Text] [Related]
35. The cytoplasmic domain of N-cadherin modulates MMP‑9 induction in oral squamous carcinoma cells.
Walker A; Frei R; Lawson KR
Int J Oncol; 2014 Oct; 45(4):1699-706. PubMed ID: 25175499
[TBL] [Abstract][Full Text] [Related]
36. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
[TBL] [Abstract][Full Text] [Related]
37. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
Tong S; Wang X; Guo X; Lu Z
J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
[TBL] [Abstract][Full Text] [Related]
39. Expression of adhesion proteins (E-cadherin and β-catenin) and cell proliferation (Ki-67) at the invasive tumor front in conventional oral squamous cell and basaloid squamous cell carcinomas.
Pereira CH; Morais MO; Martins AF; Soares MQ; Alencar Rde C; Batista AC; Leles CR; Mendonça EF
Arch Oral Biol; 2016 Jan; 61():8-15. PubMed ID: 26476747
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma.
Jiang Y; Liao L; Shrestha C; Ji S; Chen Y; Peng J; Wang L; Liao E; Xie Z
Int J Clin Exp Pathol; 2015; 8(8):9042-51. PubMed ID: 26464646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
